Patent Application
Provisional
Small
App. No. 63/401,893
· Confirmation No. 6341
Ferroptosis-HDAC Inhibitor Hybrid Anticancer Agents
Provisional Application Expired
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2022-10-17 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2022-09-12 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2022-08-29 | TR.PROV |
Provisional Cover Sheet (SB16) | 4 | View | |
| 2022-08-29 | DRW |
Drawings-only black and white line drawings | 59 | View | |
| 2022-08-29 | SPEC |
Specification | 56 | View | |
| 2022-08-29 | CLM |
Claims | 9 | View | |
| 2022-08-29 | ABST |
Abstract | 1 | View | |
| 2022-08-29 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2022-08-29 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View |
Inventors
Viranga Tillekeratne
Toledo, OH
Endri Karaj
Toledo, OH
Shaimaa Sindi
Toledo, OH
William Taylor
Toledo, OH
Attorneys & Agents of Record
Prosecution
- Customer No.
- 4859
- Docket No.
- 63161-US-PSP/D2022-16
- Confirmation No.
- 6341
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
from
UNIVERSITY OF TOLEDO
LICENSE
Recorded 2024-12-09
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2024-01-24
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 63/401,893
- Filed
- 2022-08-29
External Links